The Best Choice for Patients with Advanced Kidney Cancer – Latest Drug Clinical Trials
Targeted drugs are effective in treating advanced kidney cancer, and the side effects are relatively mild and easily tolerated by patients, bringing new hope to patients with advanced kidney cancer. The Department of Urology of Renji Hospital is the first unit that started to apply targeted therapy to treat advanced kidney cancer, and has accumulated experience in treating hundreds of patients with a treatment efficiency of 76%. With the deepening of targeted drug research, new drugs keep appearing, and the combination application of drugs is getting more and more attention, and how to choose the right patient for targeted therapy has become a hot spot for research. The Department of Urology of Renji Hospital features the diagnosis and treatment of kidney cancer, and clinical experimental research has been recognized by major international pharmaceutical companies. For patients with advanced kidney cancer, clinical trials will bring the latest drugs and the most rigorous follow-up system, and without the need to bear the expensive treatment costs, which is the best choice for patients. Patients with advanced kidney cancer are welcome to participate in the clinical trials organized by the Department of Urology of Renji Hospital! Huang Yiran, Department of Urology, Shanghai Renji Hospital
For patients with advanced kidney cancer, please contact Dr. Dong Bojun, Department of Urology, Renji Hospital, at: Dr. Dong Bojun Every Friday morning, Renji Hospital (East, 1630 Dongfang Road), Renal Tumor Clinic or E-Mail: [email protected]